Munziba Khan1, Maureen Monaghan2, Nancy Klein1, George Ruiz1,3, Anitha S John1,3. 1. Children's National Heart Institute, Children's National Health System, George Washington University School of Medicine, Washington, DC, USA. 2. Center for Translational Science, Children's National Health System, George Washington University School of Medicine, Washington, DC, USA. 3. Division of Cardiology, MedStar Washington Hospital Center, Washington, DC, USA.
Abstract
BACKGROUND: Adult congenital heart disease (ACHD) patients have high rates of untreated depression and anxiety disorders. We evaluated associations among self-reported depression symptoms and alcohol/smoking tobacco use. METHODS: From 2009 to 2013, 202 ACHD patients (45% male) completed questionnaires on depressive symptoms, anxiety symptoms, and substance use as part of routine clinical care. Data were collected by retrospective chart review. RESULTS: Mean age was 31 ± 10 years, 21% reported often feeling depressed and 33% reported feeling nervous or anxious. Sixty-one percent of patients reported some alcohol intake; 25% reported current or previous smoking tobacco use. Patients with depressive symptoms were 3× as likely to report drinking alcohol (OR 2.89; 95% CI 1.29-6.5) and 5× more likely to report smoking tobacco use (OR 5.17; 95% CI 1.49-17.87). Fourteen percent of patients were prescribed antidepressant/antianxiety medications; 43% of patients on medication reported depressive symptoms. In patients reporting symptoms, those who consumed alcohol were less likely to be on antidepressant/antianxiety medications (21%) than those who did not consume alcohol (56%). CONCLUSION: Self-reported depressive symptoms are associated with increased alcohol and smoking tobacco use by ACHD patients. Alcohol use may be a means of self-medicating for untreated depression, but further investigation is needed. Risk factors, including depressive symptoms and substance use, should be routinely assessed and addressed in ACHD patients.
BACKGROUND: Adult congenital heart disease (ACHD) patients have high rates of untreated depression and anxiety disorders. We evaluated associations among self-reported depression symptoms and alcohol/smoking tobacco use. METHODS: From 2009 to 2013, 202 ACHD patients (45% male) completed questionnaires on depressive symptoms, anxiety symptoms, and substance use as part of routine clinical care. Data were collected by retrospective chart review. RESULTS: Mean age was 31 ± 10 years, 21% reported often feeling depressed and 33% reported feeling nervous or anxious. Sixty-one percent of patients reported some alcohol intake; 25% reported current or previous smoking tobacco use. Patients with depressive symptoms were 3× as likely to report drinking alcohol (OR 2.89; 95% CI 1.29-6.5) and 5× more likely to report smoking tobacco use (OR 5.17; 95% CI 1.49-17.87). Fourteen percent of patients were prescribed antidepressant/antianxiety medications; 43% of patients on medication reported depressive symptoms. In patients reporting symptoms, those who consumed alcohol were less likely to be on antidepressant/antianxiety medications (21%) than those who did not consume alcohol (56%). CONCLUSION: Self-reported depressive symptoms are associated with increased alcohol and smoking tobacco use by ACHD patients. Alcohol use may be a means of self-medicating for untreated depression, but further investigation is needed. Risk factors, including depressive symptoms and substance use, should be routinely assessed and addressed in ACHD patients.
Authors: Ali Fakharri; Ali Jahani; Homayoun Sadeghi-Bazargani; Mostafa Farahbakhsh; Asghar Mohammadpour Asl Journal: Electron Physician Date: 2017-03-25
Authors: Leila Kasmi; Damien Bonnet; Michèle Montreuil; David Kalfa; Nikoletta Geronikola; David C Bellinger; Johanna Calderon Journal: Front Pediatr Date: 2017-03-24 Impact factor: 3.418
Authors: Tim Halling; Steffen Akkermann; Friederike Löffler; Adrian Groh; Ivo Heitland; Walter Emil Haefeli; Johann Bauersachs; Kai G Kahl; Mechthild Westhoff-Bleck Journal: Front Psychiatry Date: 2021-11-24 Impact factor: 4.157